![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Neural Analytics Receives CE Mark for the Lucid System
Neural Analytics Receives CE Mark for the Lucid System
![](https://www.fdanews.com/ext/resources/test/Device_Images6/Lucid_Tablet_Image.gif?t=1485386486&width=430)
Los Angeles–based, Neural Analytics has gained a CE Mark for its advanced ultrasound device, the Lucid M1 transcranial doppler ultrasound system (lucid system), which is a portable all-in-one ultrasound system designed for rapid triaging and monitoring of patients with brain disorders.
The device system is a battery-operated, medical-grade tablet. It uses a type of ultrasound called transcranial doppler to assess the brain’s blood vessels from outside the body.
The device received FDA marketing clearance in October 2016. — Cynthia Jessup
Upcoming Events
-
11Jul
-
18Jul
-
21Oct